Nowadays, use of continuous metabolic syndrome (cMetS) score has been suggested to improve recognition of metabolic syndrome (MetS). The aim of this study was to evaluate the validity of cMetS scores for predicting MetS.
We searched the electronic databases included MEDLINE/PubMed, Embase, ISI Web of Science, and Scopus from 1 January 1980 to 30 September 2020. Observational studies on participants with different cMetS scores were included in this meta-analysis. The sensitivity, specificity, positive likelihood ratio (LR+), negative likelihood ratio (LR) and diagnostic odds ratio (DOR) with 95% CI were calculated.
Ten studies involving a total of 25,073 participants were included. All studies had cross-sectional design. The pooled sensitivity and specificity of cMetS scores for predicting MetS were 0.90 (95% CI: 0.83 to 0.95) and 0.86 (95% CI: 0.83 to 0.89), respectively. Moreover, cMetS scores had the pooled LR+ of 6.5 (95% CI: 5.0 to 8.6), and a pooled (LR-) of 0.11 (95% CI: 0.063 to 0.21). The pooled DOR of cMetS scores to predict MetS were 57 (95% CI: 26 to 127).
The high sensitivity and specificity of cMetS scores indicates that it has a high accuracy to predict the risk of MetS. Furthermore, the cMetS scores has a good ability to rule out healthy people.
This study was registered as PROSPERO CRD42020157273.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–421. PMID: 12485966.
Amirkalali B, Fakhrzadeh H, Sharifi F, Kelishadi R, Zamani F, Asayesh H, Safiri S, Samavat T, Qorbani M. Prevalence of metabolic syndrome and its components in the Iranian adult population: a systematic review and meta-analysis. Iranian red crescent medical journal. 2015 Dec;17(12).
Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. Jama. 2012;307(5):491–7. https://doi.org/10.1001/jama.2012.39.
Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills A, Misra A. Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review. BMC Public Health. 2017;17(1):101. https://doi.org/10.1186/s12889-017-4041-1.
van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, Foco L, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014;14:9.
Marquez-Sandoval F, et al. The prevalence of metabolic syndrome in Latin America: a systematic review. Public Health Nutr. 2011;14(10):1702–13.
Eisenmann JC. On the use of a continuous metabolic syndrome score in pediatric research. Cardiovasc Diabetol. 2008;7(1):17. https://doi.org/10.1186/1475-2840-7-17.
Heshmat R, Heidari M, Ejtahed H-S, Motlagh ME, Mahdavi-Gorab A, Ziaodini H, et al. Validity of a continuous metabolic syndrome score as an index for modeling metabolic syndrome in children and adolescents: the CASPIAN-V study. Diabetology & metabolic syndrome. 2017;9(1):89. https://doi.org/10.1186/s13098-017-0291-4.
Magnussen CG, Cheriyan S, Sabin MA, Juonala M, Koskinen J, Thomson R, et al. Continuous and dichotomous metabolic syndrome definitions in youth predict adult type 2 diabetes and carotid artery intima media thickness: the Cardiovascular Risk in Young Finns Study. The Journal of pediatrics. 2016;171:97–103. e3. https://doi.org/10.1016/j.jpeds.2015.10.093
Magnussen CG, Koskinen J, Juonala M, Chen W, Srinivasan SR, Sabin MA, et al. A diagnosis of the metabolic syndrome in youth that resolves by adult life is associated with a normalization of high carotid intima-media thickness and type 2 diabetes mellitus risk: the Bogalusa heart and cardiovascular risk in young Finns studies. J Am Coll Cardiol. 2012;60(17):1631–9. https://doi.org/10.1016/j.jacc.2012.05.056.
Kelly AS, Steinberger J, Jacobs DR Jr, Hong C-P, Moran A, Sinaiko AR. Predicting cardiovascular risk in young adulthood from the metabolic syndrome, its component risk factors, and a cluster score in childhood. International Journal of Pediatric Obesity. 2011;6(sup3):e283–9. https://doi.org/10.3109/17477166.2010.528765.
Pandit D, Chiplonkar S, Khadilkar A, Kinare A, Khadilkar V. Efficacy of a continuous metabolic syndrome score in Indian children for detecting subclinical atherosclerotic risk. Int J Obes. 2011;35(10):1318–24. https://doi.org/10.1038/ijo.2011.138.
Ragland DR. Dichotomizing continuous outcome variables: dependence of the magnitude of association and statistical power on the cutpoint. Epidemiology. 1992;3:434–40. https://doi.org/10.1097/00001648-199209000-00009.
Gurka MJ, Golden SH, Musani SK, Sims M, Vishnu A, Guo Y, et al. Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the atherosclerosis risk in communities study and Jackson heart study. Diabetologia. 2017;60(7):1261–70. https://doi.org/10.1007/s00125-017-4267-6.
Brambilla P, Pietrobelli A. Behind and beyond the pediatric metabolic syndrome. Ital J Pediatr. 2009;35(1):41. https://doi.org/10.1186/1824-7288-35-41.
Mehrkash M, Kelishadi R, Mohammadian S, Mousavinasab F, Qorbani M, Hashemi ME, et al. Obesity and metabolic syndrome among a representative sample of Iranian adolescents. Southeast Asian Journal of Tropical Medicineand Public Health. 2012 May 1;43(3):756.
Shi P, Goodson JM, Hartman M-L, Hasturk H, Yaskell T, Vargas J, et al. Continuous metabolic syndrome scores for children using salivary biomarkers. PloS one. 2015;10(9). https://doi.org/10.1371/journal.pone.0138979.
Eisenmann JC, Laurson KR, DuBose KD, Smith BK, Donnelly JE. Construct validity of a continuous metabolic syndrome score in children. Diabetology & metabolic syndrome. 2010;2(1):8. https://doi.org/10.1186/1758-5996-2-8.
Shen BJ, Goldberg RB, Llabre MM, Schneiderman N. Is the factor structure of the metabolic syndrome comparable between men and women and across three ethnic groups: the Miami community health study. Ann Epidemiol. 2006;16(2):131–7. https://doi.org/10.1016/j.annepidem.2005.06.049.
Pladevall M, Singal B, Williams LK, Brotons C, Guyer H, Sadurni J, et al. A single factor underlies the metabolic syndrome: a confirmatory factor analysis: response to McCaffery et al. Diabetes Care. 2006;29(7):1720–1. https://doi.org/10.2337/dc06-0800.
Shafiee G, Kelishadi R, Heshmat R, Qorbani M, Motlagh ME, Aminaee T, et al. First report on the validity of a continuous metabolic syndrome score as an indicator for metabolic syndrome in a national sample of paediatric population—the CASPIAN-III study. Endokrynologia Polska. 2013;64(4):278–84. https://doi.org/10.5603/EP.2013.0006.
Martínez-Vizcaíno V, Martínez MS, Aguilar FS, Martínez SS, Gutiérrez RF, López MS, et al. Validity of a single-factor model underlying the metabolic syndrome in children: a confirmatory factor analysis. Diabetes Care. 2010;33(6):1370–2. https://doi.org/10.2337/dc09-2049.
Gurka MJ, Ice CL, Sun SS, DeBoer MD. A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences. Cardiovasc Diabetol. 2012;11(1):128. https://doi.org/10.1186/1475-2840-11-128.
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36. https://doi.org/10.7326/0003-4819-155-8-201110180-00009.
Khoshhali M, Heshmat R, Motlagh ME, Ziaodini H, Hadian M, Aminaei T, et al. Comparing the validity of continuous metabolic syndrome risk scores for predicting pediatric metabolic syndrome: the CASPIAN-V study. J Pediatr Endocrinol Metab. 2019;32(4):383–9. https://doi.org/10.1515/jpem-2018-0384.
Reuter CP, Andersen LB, Valim ARD, Reuter EM, Borfe L, Renner JDP, et al. Cutoff points for continuous metabolic risk score in adolescents from southern Brazil. American Journal of Human Biology. 2019;31(2). https://doi.org/10.1002/ajhb.23211.
Wiley JF, Carrington MJ. A metabolic syndrome severity score: a tool to quantify cardio-metabolic risk. Psychosom Med. 2016;78(3):A103–A4. https://doi.org/10.1016/j.ypmed.2016.04.006.
Sawant SP, Amin AS. Use of continuous metabolic syndrome score in overweight and obese children. Indian J Pediatr. 2019;86(10):909–14. https://doi.org/10.1007/s12098-019-02994-5.
Hosseini M, Sarrafzadegan N, Kelishadi R, Monajemi M, Asgary S, Vardanjani HM. Population-based metabolic syndrome risk score and its determinants: the Isfahan healthy heart program. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences 2014;19(12):1167. PMID: 25709659, 1174.
Okosun IS, Lyn R, Davis-Smith M, Eriksen M, Seale P. Validity of a continuous metabolic risk score as an index for modeling metabolic syndrome in adolescents. Ann Epidemiol. 2010;20(11):843–51. https://doi.org/10.1016/j.annepidem.2010.08.001.
Greiner M, Pfeiffer D, Smith R. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Preventive veterinary medicine. 2000;45(1–2):23–41. https://doi.org/10.1016/S0167-5877(00)00115-X.
Guseman EH, Eisenmann JC, Laurson KR, Cook SR, Stratbucker W. Calculating a continuous metabolic syndrome score using nationally representative reference values. Acad Pediatr. 2018;18(5):589–92. https://doi.org/10.1016/j.acap.2018.02.011.
de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the third National Health and nutrition examination survey. Circulation. 2004;110(16):2494–7. https://doi.org/10.1161/01.CIR.0000145117.40114.C7.
Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR, Berenson GS. The relation of childhood BMI to adult adiposity: the Bogalusa heart study. Pediatrics. 2005;115(1):22–7. https://doi.org/10.1542/peds.2004-0220.
The authors are thankful of Emam Ali clinical research development unit for their assistance.
Availability of data and materials
Please contact corresponding author for data requests.
This study was funded and designed by Alborz University of Medical Sciences.
Ethics approval and consent to participate
The Research and Ethics council of Alborz University of Medical Sciences approved the study.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Khazdouz, M., Hasani, M., Mehranfar, S. et al. Validity of continuous metabolic syndrome score for predicting metabolic syndrome; a systematic review and meta-analysis. J Diabetes Metab Disord (2021). https://doi.org/10.1007/s40200-021-00771-w
- Continuous metabolic syndrome score (cMetS)
- Metabolic syndrome